Literature DB >> 23880959

CACNA1C genotype explains interindividual differences in amygdala volume among patients with schizophrenia.

Claudia Wolf1, Holger Mohr, Thomas Schneider-Axmann, Andreas Reif, Thomas Wobrock, Harald Scherk, Susanne Kraft, Andrea Schmitt, Peter Falkai, Oliver Gruber.   

Abstract

Affective deficits are one common denominator of schizophrenia (SZ), bipolar disorder (BD) and obsessive compulsive disorder (OCD) with the amygdala indicated as one of the major structures involved in emotion regulation. Previous findings of differences in amygdala volume between healthy controls and patients with SZ, BD or OCD diverge with respect to the affected hemisphere, size and direction of the effect. Variability in the CACNA1C gene has been linked to BD, SZ as well as structural and functional variation in the amygdala in healthy people and patients with BD. We were interested to investigate whether amygdala volumes differ between hemispheres, diagnostic or genotype groups, and whether any interactive effects exist. We combined genotyping of SNP rs1006737 in CACNA1C with structural MRI measurements of relative gray matter (GM) amygdala volume in patients with SZ, BD or OCD as well as healthy controls (N Total = 72). The CACNA1C genotype showed a significant effect on relative GM amygdala volume in patients with SZ. There was a significant left versus right relative GM amygdala volume decrease in patients with SZ or BD. The effects of hemisphere and diagnosis (controls vs. patients with SZ) on relative GM amygdala volume were genotype specific. Our data suggest that the CACNA1C genotype may account for some heterogeneity in the effects of hemisphere and diagnosis on amygdala volume when comparing patients with SZ and controls and point to disturbed Ca(2+)-signaling as a plausible mechanism contributing to the pathology in patients with SZ.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23880959     DOI: 10.1007/s00406-013-0427-y

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  56 in total

1.  Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway.

Authors:  R E Dolmetsch; U Pajvani; K Fife; J M Spotts; M E Greenberg
Journal:  Science       Date:  2001-10-12       Impact factor: 47.728

Review 2.  The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings.

Authors:  S M Strakowski; M P Delbello; C M Adler
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

Review 3.  Biological pathways to adaptability--interactions between genome, epigenome, nervous system and environment for adaptive behavior.

Authors:  C Wolf; D E J Linden
Journal:  Genes Brain Behav       Date:  2011-12-13       Impact factor: 3.449

4.  The CACNA1C risk variant for bipolar disorder influences limbic activity.

Authors:  M Wessa; J Linke; S H Witt; V Nieratschker; C Esslinger; P Kirsch; O Grimm; M G Hennerici; A Gass; A V King; M Rietschel
Journal:  Mol Psychiatry       Date:  2010-03-30       Impact factor: 15.992

5.  CACNA1C (rs1006737) is associated with schizophrenia.

Authors:  M Nyegaard; D Demontis; L Foldager; A Hedemand; T J Flint; K M Sørensen; P S Andersen; M Nordentoft; T Werge; C B Pedersen; D M Hougaard; P B Mortensen; O Mors; A D Børglum
Journal:  Mol Psychiatry       Date:  2010-02       Impact factor: 15.992

6.  Brain function in carriers of a genome-wide supported bipolar disorder variant.

Authors:  Susanne Erk; Andreas Meyer-Lindenberg; Knut Schnell; Carola Opitz von Boberfeld; Christine Esslinger; Peter Kirsch; Oliver Grimm; Claudia Arnold; Leila Haddad; Stephanie H Witt; Sven Cichon; Markus M Nöthen; Marcella Rietschel; Henrik Walter
Journal:  Arch Gen Psychiatry       Date:  2010-08

Review 7.  Emotion processing and regulation in bipolar disorder: a review.

Authors:  Jennifer Townsend; Lori L Altshuler
Journal:  Bipolar Disord       Date:  2012-06       Impact factor: 6.744

8.  Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action.

Authors:  E Mogilnicka; A Czyrak; J Maj
Journal:  Eur J Pharmacol       Date:  1987-06-26       Impact factor: 4.432

Review 9.  Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited.

Authors:  Lara Menzies; Samuel R Chamberlain; Angela R Laird; Sarah M Thelen; Barbara J Sahakian; Ed T Bullmore
Journal:  Neurosci Biobehav Rev       Date:  2007-10-17       Impact factor: 8.989

10.  Meta-analysis of brain volume changes in obsessive-compulsive disorder.

Authors:  Jean-Yves Rotge; Dominique Guehl; Bixente Dilharreguy; Jean Tignol; Bernard Bioulac; Michele Allard; Pierre Burbaud; Bruno Aouizerate
Journal:  Biol Psychiatry       Date:  2008-08-21       Impact factor: 13.382

View more
  12 in total

1.  Variation in CACNA1C is Associated with Amygdala Structure and Function in Adolescents.

Authors:  Jennifer A Sumner; Margaret A Sheridan; Stacy S Drury; Kyle C Esteves; Kate Walsh; Karestan C Koenen; Katie A McLaughlin
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-09-24       Impact factor: 2.576

2.  Influence of DGKH variants on amygdala volume in patients with bipolar affective disorder and schizophrenia.

Authors:  S Kittel-Schneider; T Wobrock; H Scherk; T Schneider-Axmann; S Trost; D Zilles; C Wolf; A Schmitt; B Malchow; A Hasan; M Backens; W Reith; P Falkai; O Gruber; A Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-06-24       Impact factor: 5.270

3.  The new risk variant CACNA1C and brain circuits in schizophrenia.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-03       Impact factor: 5.270

Review 4.  Phenotypes, mechanisms and therapeutics: insights from bipolar disorder GWAS findings.

Authors:  Ming Li; Tao Li; Xiao Xiao; Jun Chen; Zhonghua Hu; Yiru Fang
Journal:  Mol Psychiatry       Date:  2022-03-29       Impact factor: 15.992

5.  Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study.

Authors:  Max R OʼDonnell; Allison Wolf; Lise Werner; C Robert Horsburgh; Nesri Padayatchi
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

6.  CACNA1C risk variant is associated with increased amygdala volume.

Authors:  T M Lancaster; S Foley; K E Tansey; D E J Linden; X Caseras
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-06-06       Impact factor: 5.270

7.  Do manual and voxel-based morphometry measure the same? A proof of concept study.

Authors:  Niels K Focke; Sarah Trost; Walter Paulus; Peter Falkai; Oliver Gruber
Journal:  Front Psychiatry       Date:  2014-04-08       Impact factor: 4.157

8.  Efficacy of N-Acetylcysteine Augmentation on Obsessive Compulsive Disorder: A Multicenter Randomized Double Blind Placebo Controlled Clinical Trial.

Authors:  Ahmad Ghanizadeh; Mohammad Reza Mohammadi; Shahla Bahraini; Zahra Keshavarzi; Ali Firoozabadi; Ali Alavi Shoshtari
Journal:  Iran J Psychiatry       Date:  2017-04

9.  CACNA1C Risk Variant and Mood Stabilizers Effects in the Prefrontal Cortical Thickness of Mexican Patients with Bipolar Disorder.

Authors:  Alejandra Monserrat Rodríguez-Ramírez; Fátima Meza-Urzúa; Valente Cedillo-Ríos; Claudia Becerra-Palars; Joanna Jiménez-Pavón; Ingrid Pamela Morales-Cedillo; Marco Antonio Sanabrais-Jiménez; Sandra Hernández-Muñoz; Beatriz Camarena-Medellín
Journal:  Neuropsychiatr Dis Treat       Date:  2020-05-12       Impact factor: 2.570

10.  Left hippocampus-amygdala complex macro- and microstructural variation is associated with BDNF plasma levels in healthy elderly individuals.

Authors:  Antonietta Manna; Fabrizio Piras; Carlo Caltagirone; Paola Bossù; Stefano L Sensi; Gianfranco Spalletta
Journal:  Brain Behav       Date:  2015-05-26       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.